[09 May 2013]
Products Affected - Description
Carbocaine injection, Hospira
Reason for the Shortage
- Hospira states that Carbocaine was on back order due to manufacturing delays.
- APP states that Polocaine vials were on back order due to increased demand.
Available Products
Carbocaine injection, Hospira
10 mg/mL, 50 mL multi-dose vial (NDC 00409-1038-50)
10 mg/mL, 30 mL preservative-free vial (NDC 00409-1036-30)
15 mg/mL, 30 mL preservative-free vial (NDC 00409-1041-30)
20 mg/mL, 20 mL preservative-free vial (NDC 00409-1067-20)
20 mg/mL, 50 mL vial (NDC 00409-2047-50)
Polocaine injection, APP
10 mg/mL, 50 mL multi-dose vial (NDC 63323-0283-57)
20 mg/mL, 50 mL multi-dose vial (NDC 63323-0296-57)
Polocaine-MPF injection, APP
10 mg/mL, 30 mL preservative-free vial (NDC 63323-0260-37)
15 mg/mL, 30 mL preservative-free vial (NDC 63323-0293-37)
20 mg/mL, 20 mL preservative-free vial (NDC 63323-0294-27)
Estimated Resupply Dates
• Hospira and APP have all presentations available.
Related Shortages
Updated
May 9, 2013; April 1, 2013; March 5, 2013; February 5, 2013; January 24, 2013; December 31, 2012; December 26, 2012; December 18, 2012; December 17, 2012; November 19, 2012; November 1, 2012; October 19, 2012; October 4, 2012; September 10, 2012; August 29, 2012, University of Utah, Drug Information Service. Copyright 2013, Drug Information Service, University of Utah, Salt Lake City, UT.
Disclaimer
This information is provided through the support of Novation to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Novation, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Novation, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Novation, ASHP nor University of Utah endorses or recommends the use of any drug.
« Back to Drug Shortage Product Bulletins